Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Transfer of digital data through an isolation
Air driven alternators for battery powered vehicles
Instrumenting configuration and system settings
Maize hybrid X95C382
Bezel-less electronic display
Wound dressings
Automated measurement of concentration and/or amount in a biological sample
  Randomly Featured Patents
Bulbous portion for a pipette
Integrated variable electrical capacitance device and method for producing said device
Lubricating means for a gear pump
Single use pouring spout and combination
Pneumatic tire including a protective rubber layer on the outer surface of the sidewalls
Gas displacement device for packaging food and non-food products
Autoclavable cap for a hazardous material container
Inflatable arm water wings for a swimmer
Method of separating materials with a concentric tubular centrifuge